Detalles de la búsqueda
1.
Comparing syngeneic and autochthonous models of breast cancer to identify tumor immune components that correlate with response to immunotherapy in breast cancer.
Breast Cancer Res
; 23(1): 83, 2021 08 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34353349
2.
Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancer.
Nat Cancer
; 2(1): 66-82, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33738458
3.
Combination therapy targeting both innate and adaptive immunity improves survival in a pre-clinical model of ovarian cancer.
J Immunother Cancer
; 7(1): 199, 2019 07 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-31362778
4.
PARP Inhibitor Efficacy Depends on CD8+ T-cell Recruitment via Intratumoral STING Pathway Activation in BRCA-Deficient Models of Triple-Negative Breast Cancer.
Cancer Discov
; 9(6): 722-737, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31015319
5.
Dysregulation in Actin Cytoskeletal Organization Drives Increased Stiffness and Migratory Persistence in Polyploidal Giant Cancer Cells.
Sci Rep
; 8(1): 11935, 2018 08 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30093656
Resultados
1 -
5
de 5
1
Próxima >
>>